Jump To Jump To Watch View Summit Archive Top 10 Things to Know About Prostate Cancer Clinical Trials March 3, 2021 Elisabeth Heath, professor of Oncology & Medicine at Karmanos Cancer Institute, and Charles Ryan, professor of Medicine at the University of Minnesota, share important things to know about prostate cancer clinical trials. Clinical trials must reflect the patient community so that new and better treatment options become available. Researchers and trial sponsors can confront health disparities by ensuring clinical trials are diverse, inclusive, and representative of the entire patient population.This session was part of our VIRTUAL ZERO Prostate Cancer Summit, a free online event that took place from February 28 to March 4, 2021.Watch Summit Session Archives At each ZERO Summit, you'll experience the Bold for Blue Awards, educational sessions, advocacy training, and more. See the video archives to find more of what you can expect to see when you join us at this year’s Summit! View Summit Archive Access to Healthcare Clinical Trials Health Equity Living with Prostate Cancer Treatment Options Videos & Webinars ZERO Prostate Cancer Summit View All Contributors Elisabeth Heath, MD, FACP, Associate Center Director, Translational Sciences Dr. Heath has more than 26 years of experience and is a leading patient advocate for the metro Detroit community. At the ZERO Prostate Cancer Summit, she spoke about funding clinical trials and how that translates into better care for prostate cancer patients. Learn more about Elisabeth Charles (Chuck) Ryan, MD, Professor of Medicine Charles J. Ryan, MD is an internationally recognized genitourinary (GU) oncologist with expertise in the biology and treatment of advanced disease as well as the supportive care of all men with prostate cancer. He was most recently the Director of the Hematology, Oncology and Transplantation Division in the Department of Medicine at the University of Minnesota, Minneapolis. He also served as the Associate Director for Clinical Research in the Masonic Cancer Center and held the B.J. Kennedy Chair in Clinical Medical Oncology. Dr. Ryan earned a BA in Philosophy, magna cum laude, from Marquette University and graduated from the University of Wisconsin Medical School. He trained at the University of Wisconsin Hospital and Clinics, serving as Chief Resident, and at Memorial Sloan Kettering Cancer Center in New York. Prior to moving to the University of Minnesota, he was on the faculty of the University of California, San Francisco, where he served as Program Leader for Genitourinary Medical Oncology and held the title of Thomas Perkins Distinguished Professor in Cancer Research. He has published over 200 articles and chapters in the world’s leading medical journals. He is the author of the book The Virility Paradox: The Vast Influence of Testosterone on Our Bodies, Minds, and the World We Live In, released in February 2018. Dr. Ryan is also the Leader of the Advanced Prostate Cancer Cadre in the Alliance for Clinical Trials in Oncology, a national clinical trials group, and past Chair of the NCI GU Steering Committee’s Prostate Cancer Task Force. Dr. Ryan, who goes by the name Chuck, is a native of Appleton, Wisconsin. He has three children with his wife, Jessica: identical twin daughters Cate and Elise, and a son, Patrick. Learn more about Charles Shelby Moneer, Vice President, Patient Programs & Education Missouri native dreaming of the beaches in basically any location that isn't land-locked. Lover of exercise, sports, candy, sushi, and coffee. Fiercly loyal to my family and friends. Learn more about Shelby More for you
Elisabeth Heath, professor of Oncology & Medicine at Karmanos Cancer Institute, and Charles Ryan, professor of Medicine at the University of Minnesota, share important things to know about prostate cancer clinical trials. Clinical trials must reflect the patient community so that new and better treatment options become available. Researchers and trial sponsors can confront health disparities by ensuring clinical trials are diverse, inclusive, and representative of the entire patient population.This session was part of our VIRTUAL ZERO Prostate Cancer Summit, a free online event that took place from February 28 to March 4, 2021.Watch
Summit Session Archives At each ZERO Summit, you'll experience the Bold for Blue Awards, educational sessions, advocacy training, and more. See the video archives to find more of what you can expect to see when you join us at this year’s Summit! View Summit Archive
Access to Healthcare Clinical Trials Health Equity Living with Prostate Cancer Treatment Options Videos & Webinars ZERO Prostate Cancer Summit View All